Weiss, Jeffrey – Trademark Portfolio
Entity Type: 01
Weiss, Jeffrey has 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include INFUSION CENTER OF NEW JERSEY. The portfolio includes 1 registered trademark. Filings span 5 Nice Classification classes, led by Class 35 (Advertising & Business) and Class 41 (Education & Entertainment). This trademark owner is based in Wyckoff, NJ.
419 Weymouth Drive
Wyckoff, NJ 07481
Showing of trademarks Trademarks
Trademark Classifications
Weiss, Jeffrey's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Insurance; financial affairs; monetary affairs; real estate affairs
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Weiss, Jeffrey have?
Weiss, Jeffrey has 6 U.S. trademarks filed with the USPTO. Of these, 1 registered, 5 abandoned.
What trademark classes does Weiss, Jeffrey file in?
Weiss, Jeffrey files trademarks across 5 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 41 (Education & Entertainment), Class 36 (Insurance & Financial), Class 44 (Medical Services), Class 39 (Transportation & Storage). Class 35 covers advertising; business management; business administration; office functions.
What are Weiss, Jeffrey's most well-known trademarks?
Weiss, Jeffrey's registered trademark portfolio includes well-known marks such as INFUSION CENTER OF NEW JERSEY. These are among 1 currently registered trademark in the portfolio.
What is Weiss, Jeffrey's trademark registration success rate?
Weiss, Jeffrey has a 17% trademark registration rate, with 1 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.